Clinical trials
Phase 2/3 Nervous System Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AO GENERIUM | 1 |
| Abcuro, Inc. | 1 |
| AstraZeneca | 1 |
| Auspex Pharmaceuticals, Inc. | 1 |
| Centessa Pharmaceuticals (UK) Limited | 1 |
| Lahey Clinic | 1 |
| Mediforum Ltd., Co. | 1 |
| University of California, Davis | 1 |
| University of California, San Diego | 1 |
| University of Melbourne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 12 |
| Central Nervous System Diseases | 7 |
| Brain Diseases | 4 |
| Mental Disorders | 3 |
| Neurologic Manifestations | 3 |
| Alzheimer Disease | 2 |
| Cardiovascular Diseases | 2 |
| Cerebrovascular Disorders | 2 |
| Dementia | 2 |
| Dyskinesias | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.